We are pleased to offer patients INVOcell intravaginal incubation, a new mid-point fertility treatment option between an intrauterine insemination (IUI) and in vitro fertilization (IVF). INVOcell is a patented medical device used in the treatment of infertility that enables egg fertilization and early embryo development to take place in the woman’s body, or in vivo. This FDA approved device is a less invasive, lower cost, fertility treatment that helps a select patient population achieve pregnancy.
The INVOcell procedure costs 40% less than traditional IVF due to less time commitment from the laboratory, less medication, fewer blood draws and ultrasound monitoring appointments. This procedure increases access to care and allows patient to be more involved in the process. For more information on the INVOcell procedure and timeline, click here.
Our board certified reproductive endocrinologists and infertility specialists (REI), Dr. Amber R. Cooper and Dr. Julie S. Rhee, and our laboratory director, Dr. Shawn Zimmerman, received hands-on training with Dr. Kevin Doody at his Texas laboratory. Dr. Doody, of the Center for Assisted Reproduction Embryo, spearheaded the initial clinical trail and has performed more INVOcell procedures than any doctor in the country.
“It was important for us to visit Dr. Doody’s lab and understand what protocols and procedures he uses. This training will help us better care for our patients and increase the number of successful outcomes,” said. Dr. Cooper, “Assisted reproductive technology (ART) is an ever-changing, fast paced field of medicine that requires continuous learning and collaboration with other top notch REIs across the country. When this device was originally approved it had good success rates. Now, we have worked with collaborators in order to offer some of the highest success rates in the country comparable to IVF“